Barclays »

Skye Bioscience shares owned by Barclays

Quarter-by-quarter ownership of Skye Bioscience (SKYE) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Skye Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Skye Bioscience held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Skye Bioscience by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $226k 58k 3.90
2024-06-30 $340k 42k 8.03

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Opt Put Option (QQQ)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple Opt Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Tesla Opt Put Option (TSLA)
Ishares Tr Fund (HYG)
Facebook Inc cl a (META)
Berkshire Hathaway (BRK.B)
Broadcom (AVGO)
Visa (V)
Alphabet Opt Put Option (GOOG)

View all positions for Barclays

Top funds holding Skye Bioscience

5AM Venture Management
Versant Venture Management
Baker Bros. Advisors
Altium Capital Management
Logos Global Management
Sphera Funds Management
BlackRock
BlackRock
Schonfeld Strategic Advisors
Henderson Group
Ensign Peak Advisors
Vanguard Group
CVI Holdings
Driehaus Capital Management
Alyeska Investment Group

View all funds holding Skye Bioscience